A retrospective study to assess efficacy, safety, long term remission rate and overall survival in patients who received cladribine as first line treatment
Latest Information Update: 08 Jan 2021
At a glance
- Drugs Cladribine (Primary) ; Cladribine (Primary)
- Indications Hairy cell leukaemia
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology